Document is current

Article History

Accepted: 19 September 2021

First Online: 8 October 2021

Declarations

:

: INMI “Lazzaro Spallanzani” Ricerca Corrente grants from the Italian Ministry of Health.

: Adriana Ammassari (A.Am) received speaker’s fees from AbbVie, Bristol Myers Squibb, Gilead, Janssen Cilag, Merck, and ViiV, and participated in advisory boards for Merck and Janssen; Andrea Antinori (A.An) received personal fees for consultancy and lectures from AbbVie, Bristol Myers Squibb, Gilead, Janssen, Merck, and ViiV and research institutional grants from Bristol Myers Squibb, Gilead, Janssen, and ViiV. Rita Bellagamba (R.B.) received speaker fees from Bristol Myers Squibb, Gilead, Janssen Cilag, Merck, and ViiV; Stefania Cicalini (S.C.) received speaker’s fees from AbbVie, Bristol Myers Squibb, Gilead, Janssen Cilag, Merck, and ViiV. All other authors have none to declare.

: The study was approved by the local ethics committee (approval reference number 20/2015).

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Helsinki Declaration. Enrolled patients provided written informed consent.

: Not applicable.

: Data are available on request.

: Not applicable.

: Conceptualization, I.M., M.T., and A.Am; methodology, S.N.; formal analysis, P.L.; investigation, G.F., R.B., E.G., A.V., and S.C.; preparation for writing original draft, I.M., M.T., and A.Am; review and editing of draft, I.M. and M.T.; supervision, A.An and C.A; funding acquisition, A.An. All authors have read and agreed to the published version of the manuscript.